II
ImmunoVec, Inc.
SEC filingOther Technology · Los Angeles, CA
Amount raised$12.7Msold at filing
Total offering$15M$2.3M still open
Investors in the raise10count reported to the SEC
FiledJul 14, 2026first sale Jun 29, 2026
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Douglass LorenzenExecutive Officer, Director, Promoter
Ryan WongExecutive Officer, Director
Chris LucasDirector
William WoodwardExecutive Officer, Director
Executive officers, directors and promoters as listed on the Form D.